drugset / Trial / NCT00487422
Efficacy and Safety Study of Prucalopride for the Treatment of Elderly Patients With Chronic Constipation
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether prucalopride is safe and effective in the treatment of chronic constipation in elderly patients. Hypothesis: Prucalopride 2 mg and 4 mg given once daily for 12 weeks is superior to placebo for the treatment of patients with chronic constipation and is well tolerated in those patients
Timeline
- Start
- 1998-10
- Primary completion
- 1999-09
- Completion
- 1999-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prucalopride | Small molecule | 1 mg | — |
| Comparator | Prucalopride | Small molecule | 2 mg | — |
| Comparator | Prucalopride | Small molecule | 4 mg | — |